Resolutions

All English translations are courtesy translations only. Only the German versions are binding.

Resolution of 18 April 2013: Pharmaceuticals on the existing market (58.4 kB)
Justification of the resolution of 18 April 2013 (214.9 kB)

Resolution of 17 April 2014: Discontinuation of benefit assessments of pharmaceuticals on the existing market (40.6 kB)

 

Page
Active Substance Name Therapeutic Area Date of Resolution
Canagliflozin/ Metformin (135.0 kB) Vokanamet® Diabetes Mellitus, Type 2 05/02/2015
Cholic acid (86.3 kB) Orphacol® Digestive System Diseases Metabolism, Inborn Errors 06/11/2014
Cobicistat (105.2 kB) Tybost® HIV Infections 18/09/2014
Colestilan (216.7 kB) BindRen® Hyperphosphatemia 01/10/2013
Crizotinib (178.0 kB) Xalkori® Carcinoma, Non-Small-Cell Lung 02/05/2013
Dabrafenib (72.8 kB) Tafinlar® Melanoma 03/04/2014
Daclatasvir (365.6 kB) Daklinza® Hepatitis C, Chronic 19/02/2015
Dapagliflozin (114.3 kB) Forxiga® Diabetes Mellitus, Type 2 06/06/2013
Dapagliflozin/ metformin (139.2 kB) Xigduo® Diabetes Mellitus, Type 2 07/08/2014
Decitabine (84.5 kB) Dacogen® Leukemia, Myeloid 02/05/2013
Dimethyl fumarate (112.1 kB) Tecfidera® Multiple Sclerosis 16/10/2014
Dulaglutide (302.8 kB) Trulicity® Diabetes Mellitus, Type 2 16/07/2015
Eliglustat (98.4 kB) Cerdelga® Gaucher Disease 01/10/2015
Elosulfase alfa (163.6 kB) Vimizim® Mucopolysaccharidosis IV 20/11/2014
Elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (97.7 kB) Stribild HIV Infections 05/12/2013
Empagliflozin (241.5 kB) Jardiance® Diabetes Mellitus, Type 2 05/02/2015
Emtricitabine, rilpivirine, hydrochloride, tenofovir, disoproxil fumarate (79.1 kB) Eviplera® HIV Infections 19/06/2014
Emtricitabine, rilpivirine, tenofovir disoproxil (80.8 kB) Eviplera® HIV Infections 05/07/2012
Enzalutamide (82.9 kB) Xtandi® Prostatic Neoplasms 20/02/2014
Enzalutamide (new therapeutic indication) (190.4 kB) Xtandi™ Prostatic Neoplasms 18/06/2015
Eribulin (174.8 kB) Halaven® Breast Neoplasms 19/04/2012
Eribulin (new therapeutic indication) (183.6 kB) Halaven® Breast Neoplasms 22/01/2015
Extract of cannabis sativa (75.8 kB) Sativex® Spasticity due to Multiple Sclerosis 21/06/2012
Fampridine (66.1 kB) Fampyra® Multiple Sclerosis 02/08/2012
Fidaxomicin (93.9 kB) Dificlir® Clostridium Infections 04/07/2013
Fingolimod (208.0 kB) Gilenya® Multiple Sclerosis 29/03/2012
Fingolimod (expiry of time limitation) (226.7 kB) Gilenya® Multiple Sclerosis 01/10/2015
Fingolimod (new therapeutic indication) (232.3 kB) Gilenya® Multiple Sclerosis 18/12/2014
Fluticasone furoate / vilanterol (64.9 kB) Relvar® Ellipta® Pulmonary Disease, Chronic Obstructive 20/03/2014
Ibrutinib (201.1 kB) Imbruvica® Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, Mantle-Cell 16/04/2015
Page